| Product Code: ETC8555392 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, New Zealand`s bronchodilator import shipments mainly originated from Australia, Metropolitan France, Spain, Ireland, and Germany. Despite the low concentration indicated by the Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) from 2020 to 2024 stood at a steady 3.11%. However, there was a notable decline in the growth rate from 2023 to 2024, with a decrease of -16.18%. This market trend suggests a stable demand for bronchodilators in New Zealand, with potential shifts in sourcing countries impacting future import dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Bronchodilators Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Bronchodilators Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Bronchodilators Market - Industry Life Cycle |
3.4 New Zealand Bronchodilators Market - Porter's Five Forces |
3.5 New Zealand Bronchodilators Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 New Zealand Bronchodilators Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 New Zealand Bronchodilators Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
4 New Zealand Bronchodilators Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in respiratory diseases prevalence in New Zealand |
4.2.2 Growing awareness about bronchodilators and their benefits |
4.2.3 Technological advancements in bronchodilator products |
4.2.4 Favorable reimbursement policies for bronchodilator treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for bronchodilator approval and marketing |
4.3.2 Competition from alternative treatments such as inhalers and corticosteroids |
4.3.3 High cost associated with some bronchodilator medications |
5 New Zealand Bronchodilators Market Trends |
6 New Zealand Bronchodilators Market, By Types |
6.1 New Zealand Bronchodilators Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Bronchodilators Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 New Zealand Bronchodilators Market Revenues & Volume, By Asthma, 2021- 2031F |
6.1.4 New Zealand Bronchodilators Market Revenues & Volume, By Chronic obstructive pulmonary disease (COPD), 2021- 2031F |
6.2 New Zealand Bronchodilators Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Bronchodilators Market Revenues & Volume, By Sympathomimetics, 2021- 2031F |
6.2.3 New Zealand Bronchodilators Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.2.4 New Zealand Bronchodilators Market Revenues & Volume, By Phosphodiesterase Inhibitor, 2021- 2031F |
6.2.5 New Zealand Bronchodilators Market Revenues & Volume, By Combination Drugs, 2021- 2031F |
6.3 New Zealand Bronchodilators Market, By Route Of Administration |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Bronchodilators Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 New Zealand Bronchodilators Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.4 New Zealand Bronchodilators Market Revenues & Volume, By Inhaler, 2021- 2031F |
7 New Zealand Bronchodilators Market Import-Export Trade Statistics |
7.1 New Zealand Bronchodilators Market Export to Major Countries |
7.2 New Zealand Bronchodilators Market Imports from Major Countries |
8 New Zealand Bronchodilators Market Key Performance Indicators |
8.1 Patient adherence rate to bronchodilator treatment plans |
8.2 Number of healthcare professionals prescribing bronchodilators |
8.3 Rate of new bronchodilator product launches |
8.4 Average time to market for new bronchodilator products |
8.5 Number of clinical trials evaluating bronchodilator efficacy and safety |
9 New Zealand Bronchodilators Market - Opportunity Assessment |
9.1 New Zealand Bronchodilators Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 New Zealand Bronchodilators Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 New Zealand Bronchodilators Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
10 New Zealand Bronchodilators Market - Competitive Landscape |
10.1 New Zealand Bronchodilators Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Bronchodilators Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here